Xencor | XNCR - PE Price to Earnings


Xencor reported $29.92 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen USD 25.31 15.82 Dec/2025
AstraZeneca USD 27.29 5.8 Dec/2025
Biogen USD 14.02 4.63 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
J&J USD 23.62 0.86 Dec/2025
Merck USD 13.92 5.08 Dec/2025
Novartis USD 15.74 0.15 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Xencor USD 29.92 3.22 Sep/2022